Visual outcome after ND: YA Glaser posterior capsulotomy in pseudophakic patient
Verma A.1,
Singh A.2, Patel S.3, Rana R.4, Jain P.5
1Dr.
Abha Verma, Associate Professor, Dr.
Ankit Singh, Senior Resident; above two authors are attached with
Department of Ophthalmology, Aurobindo Medical College and Postgraduate
Institute, Indore (M.P.), Dr. Siddharth Patel, Senior Resident, All India Institute of Medical Sciences, Rishikesh, Dr. Rimpi Rana, Senior Resident, All India Institute of Medical Sciences, Rishikesh ,, Junior Resident, Department of Ophthalmology, Shri Aurobindo
Medical College and Postgraduate Institute, Indore, M.P, India.
Corresponding
Author: Dr. Abha Verma, Associate Professor, Department of
Ophthalmology, Aurobindo Medical College and Postgraduate Institute, Indore, M.P.,
India, Email: drabhaverma17@gmail.com
Abstract
Background:
Posterior
capsular opacification (PCO) also called as “after cataract” is a common
complication following extra capsular cataract surgery with or without posterior
chamber intraocular lens implantation.An opaque membrane develops as retained
cells proliferate and migrate on the posterior capsular surface. Material
and Methods: The study included a
total of 100 eyes of 100 patients who were diagnosed to have posterior capsular
opacification and were fulfilling all the inclusion and none of the exclusion
criteria. After that they were taken for a detailed clinical examination. All
patients underwent Nd:YAG laser capsulotomy and were followed up at 1 week, 1
month and at 3 months. At every follow-up detailed examination was done. BCVA
and any complications were noted.Results:Of the 100 patients, 45
(45%) were male and 55 (55%) were female. Majority of the patients were in the
age group 61-70 years. The average time interval between cataract surgery and
Nd-YAG laser capsulotomy was between 2-4 years. In the type of PCO seen,84
(84.0%) patients were having Elsching pearls type of PCO, 8 (8.0%) patients
were having fibrous type of PCO and 8 (8.0%) patients were having Sommering
ring type of PCO. The pre laser visual acuityin more than 62% of eyes was 6/60
to FC while 38% had visual acuity of 6/36 to 6/18. Visual acuity of 6/18 or
better was achieved in 27% of eyes while 73% recovered to 6/12 to 6/6. None of
these eyes showed further deterioration in visual acuity. The highest energy requirement
was in the Fibrous PCO s0.89 ± 0.15 J, followed by Sommering Ring PCO 0.70 ±
0.17 J and least energy was in Elsching pearls 0.47 ± 0.24 J. The comparison of
mean energy between the type of PCO was found to be statistically significant
(P<0.05), showing that the mean energy was varying between the types of PCO.
Conclusion: Neodymium-YAG capsulotomy for PCO is rewarding procedure
inadults and has good visual outcome.
Keywords:
Posterior
capsular opacification, Nd-YAG, Visual outcome
Introduction
Cataract is the main cause of avoidable blindness [1]. Despite some recent advances
in the field of cataract potential drug treatments, surgery is still acknowledged
to be the most effective treatment option [2]. Despite
the meticulous surgery and removal of the cataractous lens, the lens epithelial
cell stillposes a threat to the long-term outcome of the surgery. Postoperative
opacification of initially clear posterior capsules occurs frequently in
patients after the surgery. Time for opacification is highly variable varying
from months to years in adults. The most convenient way of the removal of the
posterior capsule opacification is toclearing the visual axis by creating a
central opening in the opacified posterior capsule using Nd – YAG laser [3].Itis
a solid-state laser with a wave length of 1064nm that can disrupt ocular
tissues by achieving optical breakdown with a short, high-power pulseresulting
in ionization, or plasma formation that causes acoustic and shock waves that
disrupt tissue.
Contraindications
to laser capsulotomy can be divided into absolute and relative. Corneal scars, irregularities, or
edema that interfere with target visualization or make optical breakdown
unpredictable and inadequate stability of the eye are absolute
contraindications while glass intraocular lens, known or suspected cystoid
macular edema, active intraocular inflammation, high risk for retinal
detachment are relative contraindications.
Purpose
Primary: To
study the visual outcome post capsulotomy after the cataract surgery
Secondary: To assess the energy
required in ND:YAG for different types of the PCO
Material and Methods
Consent
from ethical committee for the study was taken. The procedures followed were in
accordance with the ethical standards committee on human experimentation
(institutional or regional) and with the Helsinki Declaration of 1975, as
revised in 2000. The present study was a cross sectional study and included 100
patients attending outpatient Department of Ophthalmology from January 2017 to
January 2018 and willing to provide their voluntary written informed consent. Consent
from each patient was taken before the procedure.
Pre laser work up: Each
patient was thoroughly evaluated with the help of slit lamp. Best corrected
visual acuity (BCVA) was noted along with IOP. Both the pupils were dilated
using a short acting mydriatic drug (0.8% tropicamide and 5% phenyephrine) and
then the patient was made to sit for 30 minutes. After 30 minutes the
dilatation of the pupil was assessed along with complete slit lamp examination.
On slit lamp the type of PCO was assessedand 5-step photography was done,
followed by fundus examination with VOLK 90D orindirect 20D lens.
Procedure:Topical
anaestheticwas instilled in the eye tobe lasered. The patient was made to sit
on ZEISS ND: YAG laser machine. The Abraham yag capsulotomy lens was fixed on
the eye with the help of viscoelastic. The energy of the laser was fixed and
then shots were taken and modified according to type of PCO.
Post laser work up and
follow up: After the procedure, the patient was made
to sit for 10 to 15 minutes. Post Yagprocedure topical beta blocker was
instilled into the lasered eye and then the patient was asked to come for follow-up
after 1 week. The patient was sent home with a topical antibiotic drop along
with a mild steroid (dexamethasone) to be instilled 4 times a day for 1 week.
Along with this a beta blocker was added to be instilled twice a day for 1
week. At 1 week follow-up the IOP and BCVA of the patient was recorded.
All
the data was recorded in a customized proforma designed for the study purpose.
Results
In
our study 100 patients were studied which included 55 (55.0%) females and 45
(45.0%) males, showing a female preponderance. There were 7 (7.0%) patients in
the age group 30-40 years, 14 (14.0%) patients were in the age group 41-50
years, 31 (31.0%) patients were in the age group 51-60 years, 36 (36.0%)
patients were in the age group 61-70, 10 (10.0%) patients were in the age group
71-80 years and 2 (2.0%) patients were in the age group >80 years.Majority of
the patients were in the age group 61-70 years(36%).
84
(84.0%) patients were having Elsching pearls type of PCO (Figure 1), 8 (8.0%)
patients were having fibrous type of PCO (Figure 2) and 8 (8.0%) patients were
having Sommering ring type of PCO (Figure 3). Majority of the patients were
having Elsching pearls type of PCO [Figure 4].
The
mean age in Elsching pearls was 60.36 ± 11.46 years, in Fibrous it was 60.50 ±
10.66 years and in the Sommering Ring it was 56.75 ± 14.46 years. The
comparison was found to be statistically not significant (P>0.05). There was
comparable distribution of males and females in relation to type of PCO
(P>0.05).
The
time interval between cataract surgery and Nd-YAG laser capsulotomy was noted.
25 (25.0%) patients had duration from surgery from 1-2 years, 62 (62.0%)
patients had duration from surgery from 2-4 years and 13 (13.0%) patients had
duration from surgery of more than 4 years. Most of the patients had duration
from surgery between 2-4 years (62%).
In
38 (38.0%) patients the pre-YAG vision was 6/36 to 6/18 and in 62 (62.0%)
patients the pre-YAG vision was FC to 6/60. Post YAG, in 73 (73.0%) patients
the Post-YAG vision was 6/12 to 6/6 and in 27 (27.0%) patients the Post-YAG
Vision was 6/36 to 6/18. Majority of the patients were having Post-YAG Vision
of 6/12 to 6/6. [Figure 5].
Figure-1:
Elsching’s pearls
Figure-2:
Fibrous type
Figure-3:
Sommering ring
Figure-4:
Distribution according to the type of PCO
Figure-5:
Comparison of pre and post-YAG vision
Table-1:
Comparison of mean IOP in before and after YAG treatment in relation to PCO
Type of PCO |
IOP |
No. |
IOP [Mean ± SD] |
‘t’ value |
P value |
Elsching
Pearls |
Pre
YAG IOP |
84 |
16.79
± 2.03 |
2.053,
df=83 |
0.043* |
Post
YAG IOP |
84 |
16.18
± 2.43 |
|||
Fibrous |
Pre
YAG IOP |
8 |
16.25
± 3.28 |
2.049,
df=83 |
0.080,
NS |
Post
YAG IOP |
8 |
14.00
± 1.07 |
|||
Sommering
Ring |
Pre
YAG IOP |
8 |
15.00
± 2.39 |
- |
- |
Post
YAG IOP |
8 |
15.00
± 2.39 |
|||
Overall |
Pre
YAG IOP |
100 |
16.61
± 2.21 |
2.587,
df=99 |
0.011* |
Post
YAG IOP |
100 |
15.91
± 2.42 |
The
comparison of mean IOP before and after YAG treatment in relation to type of
PCO was done using paired‘t’ test. The mean Pre YAG IOP in Elsching Pearls was
16.79 ± 2.03 mm Hg, while post YAG IOP was 16.18 ± 2.43 mm Hg. The difference
was found to be statistically significant (P<0.05), showing that there is a
significant decrease in the Post YAG IOP in comparison to the Pre YAG IOP in
the Elsching Pearls. The mean Pre YAG IOP in Fibrous was 16.25 ± 3.28 mm Hg,
while post YAG IOP was 14.00 ± 1.07 mm Hg. The difference was found to be
statistically not significant (P>0.05), showing a comparable Post YAG IOP in
comparison to the Pre YAG IOP.The mean Pre YAG IOP in Sommering Ring was 15.00
± 2.39 mm Hg, while post YAG IOP was 15.00 ± 2.39 mm Hg. The difference could
not be calculated as the difference of the standard deviation of pre and post
YAG IOP was found to be zero. The mean overall Pre YAG IOP was 16.61 ± 2.21 mm
Hg, while post YAG IOP was 15.91 ± 2.42 mm Hg. The difference was found to be
statistically significant (P<0.05), showing that there is a significant
decrease in the overall Post YAG IOP in comparison to the overall Pre YAG IOP
[Table 1].
Table-2:
Comparison of mean energy in relation to type of PCO
Type of PCO |
Number |
Mean ± SD |
F value |
P value |
Post-hoc Tukey |
||
Elsching Pearls – Fibrous |
Elsching Pearls – Sommering Ring |
Fibrous – Sommering Ring |
|||||
Elsching
Pearls |
84 |
0.47
± 0.24 |
14.732 |
0.000* |
0.000* |
0.021* |
0.242,
NS |
Fibrous |
8 |
0.89
± 0.15 |
|||||
Sommering
Ring |
8 |
0.70
± 0.17 |
|||||
Total |
100 |
|
|
|
The mean energy
in Elsching pearls was 0.47 ± 0.24 J, in Fibrous it was 0.89 ± 0.15 J and in
the Sommering Ring it was 0.70 ± 0.17 J. The highest energy was in the Fibrous
PCO. The comparison of mean energy between the type of PCO was found to be statistically
significant (P<0.05), showing that the mean energy was varying between the
types of PCO. There was significantly lower energy in Elsching Pearls in
comparison to the Fibrous and Sommering Ring PCOs (P<0.05), while no
statistically significant difference seen between Fibrous and Sommering Ring
(P>0.05). [Table 2]
Table-3:
Comparison of mean number of YAG shots in relation to type of PCO
Type of PCO |
Number |
Mean ± SD |
F value |
P value |
Post-hoc Tukey |
||
Elsching Pearls – Fibrous |
Elsching Pearls – Sommering Ring |
Fibrous – Sommering Ring |
|||||
Elsching
Pearls |
84 |
107.56
± 17.18 |
2.923 |
0.059,
NS |
0.360,
NS |
0.094,
NS |
0.851,
NS |
Fibrous |
8 |
99.38
± 9.94 |
|||||
Sommering
Ring |
8 |
95.00
± 3.46 |
|||||
Total |
100 |
|
|
|
The mean number of YAG shots in
Elsching pearls was 107.56 ± 17.18, in Fibrous it was 99.38 ± 9.94 and in the
Sommering Ring it was 95.00 ± 3.46. The comparison of mean number of YAG shots
between the type of PCO was found to be statistically not significant
(P>0.05), showing that the mean number of YAG shots was comparable in
relation type of PCO. [Table 3]
Discussion
Age and sex-A
total of 100 patients were studied who presented with PCO post cataract surgery
between the ages of 30 to those over 80 years, with most the patients 36%
falling between the ages of 61-70 years. The sex distribution was a 55% female
to 45% male ratio with female preponderance.
Opacification
post-surgery- The Neodymium-YAG laser has become
popular non-invasive technique of creating a posterior capsulotomy to create an
opening in the posterior lens. Its safety and efficacy can be argued but it has
established its place as a standard treatment for PCO replacing surgical
capsulotomy. The time period between cataract extraction and performing
Neodymium-YAG laser capsulotomy at average was 2-4 years in our study while it
was reported as 2.49 years by Hasan et al [4], and 24 months in another study
by Kundi NK et al [5]. Emery, Wilhelmus, and Rosenberg [6] found opacification
in 28% of their patients with 2-3 years of follow-up. Late opacification of the
posterior capsule after 3-5 years has been reported to be approximately 50%.
Visual
Acuity post treatment- According to our findings the Post-
YAG Vision in 73.0% patients was 6/12 to 6/6 and in 27.0% patients the Post-YAG
Vision was 6/36 to 6/18. Majority of the patients were having Post-YAG Vision
of 6/12 to 6/6. In a study by Bilal Bashir et al[4] the post treatment visual
acuity was 6/6 in 12 (40%), 6/9 in 9 (30%) patients, 6/12 in 6 (20%) patients
and 6/18 in 2 (6.66%) and 6/24 in 1(3.33%) patients. A study conducted by Younas Khan et al[8] showed post-YAG
Visual acuity of 6/18 or better was achieved in 60.2% of eyes while 12.0%
recovered to 6/9 and 3.4% achieved 6/6.
Types
of PCO- In our study, according to type of PCO studied,
84.0% patients had Elsching pearls type of PCO, 8.0% patients were having
fibrous type of PCO and 8.0% patients hadSommering ring type of PCO. Hence,
majority of the patients were having Elsching pearls type of PCO. However a
study by Younas Khan et al [8] showed
Capsular fibrosis (62%) was the predominant type of PCO. The
relative incidence of different types of PCO showed that the capsular fibrosis
was the predominant type of PCO as compared to Hasan, et al [4] who reported
Elschnig’s pearls in pseudophakic and secondary fibrosis in aphakic eyes
Complications-
Elevated
IOP is recognized as the most common, although usually transient, complication
following Nd: YAG laser capsulotomy. This is similar to a study done by
Gopinath et al [9] where they found increased IOP in 30% patients, but the rise
was mostly in the range of 21-27 mm Hg. However in our study we found the mean
overall Pre YAG IOP was 16.61 ± 2.21 mm Hg, while post YAG IOP was 15.91 ± 2.42
mm Hg. There is a significant decrease in the overall Post YAG IOP in
comparison to the overall Pre YAG IOP.
YAG
shots, energy used- Only few cases in required high energy
levels, probably this may correlate with the learning curve. Once the surgeon
get experienced the energy level required can come down, the other reason may
be the fixation of eyes required during the process, if the patient moves the
eye, the energy level will be more ,as the shots are wasted, hence fixating
lens should be used to decrease the level of energy and shots[10]. The mean
energy in Elsching pearls was 0.47 ± 0.24 J, in Fibrous it was 0.89 ± 0.15 J
and in the Sommering Ring it was 0.70 ± 0.17 J. The highest energy was in the
Fibrous PCO. In the comparison of number of YAG shots in relation to type of
PCO. The mean number of YAG shots in Elsching pearls was 107.56 ± 17.18, in
Fibrous it was 99.38 ± 9.94 and in the Sommering Ring it was 95.00 ± 3.46.
Conclusion
Nd: YAG laser
capsulotomy is asafe and effective method to treat PCO. It is non-invasive and
avoids all the complications associated with surgical capsulotomy such as
endophthalmitis and wound related problems and local anaesthesia such as
perforation and haemorrage etc. Majority of the patients were in the age group
61-70 years. Elsching’s pearls were present in maximum patients. Majority of patients had significant
improvement in visual acuity with 73% having visual improvement between 6/6 to
6/12. There is a significant decrease in the overall Post YAG IOP in
comparison to the overall Pre YAG IOP.
Corneal oedema and iritis were seen as post laser complications.
References
1.
Swenor BK, Simonsick EM, Ferrucci L, Newman AB, Rubin S, Wilson V.
Visual impairment and incident mobility limitations: the health, aging
and body composition study. J Am Geriatr Soc. 2015;
63(1):46–54.doi:10.1111/jgs.13183.[pubmed]
2. Keeffe J, Taylor HR, Fotis K, Pesudovs K, Flaxman SR, Jonas
JB, Leasher J, Naidoo K, Price H, White RA, Wong TY, Resnikoff S, Bourne RR,
Vision Loss Expert Group of the Global Burden of Disease Study Prevalence and
causes of vision loss in Southeast Asia and Oceania: 1990-2010. Br J Ophthalmol. 2014; 95(8):586–591.doi:
10.1136/bjophthalmol-2013-304050.[pubmed]
3.
Apple DJ, Peng Q, Visessook N, et al. Eradication of posterior
capsule opacification: documentation of a marked decrease in Nd:YAG
laser posterior capsulotomy rates noted in an analysis of 5416
pseudophakic human eyes obtained postmortem. Ophthalmology. 2001
Mar;108(3):505-18.[pubmed]
4. Hasan KS, Adhi MI, Aziz M, et
al. Nd:YAG laser posterior capsulotomy. Pak Ophthalmol. 1996; 12: 3-7.
5.
Kundi NK, Younas M. Nd-YAG Laser posterior capsulotomy. J Med Sciences.
1998; 8: 90-4.
6. Emery J. Capsular opacification after cataract surgery. CurrOpinOphthalmol. 1999 Feb;10(1):73-80.[pubmed]
7. Bilal Bashir et al. Visual
outcome after Nd: Yag Laser Anterior Capsulotomy in Patients with Anterior
Capsular Contraction Syndrome. Ophthalmology Update Vol. 12. No. 4,
October-December 2014
8. Mohammad Younas Khan et al.
Visual Outcome after Nd-YAG Capsulotomy in Posterior Capsule Opacification. Pak
J Ophthalmol 2006, Vol. 22 No.2
9. Gopinath GS, Satish K,
Srivastava N, Patil S, Afshan R. Visual Outcome and Complications of YAG Laser
Therapy for Posterior Capsular Opacification Following Cataract Surgery. Int J
Sci Stud 2015;3(3):65-68.
10. Pankaj Soni et al. Nd-YAG laser
posterior capsulotomy and visual outcome. Indian Journal of Clinical and
Experimental Ophthalmology, July-September,2016;2(3): 271-27